To investigate procalcitonin (PCT) levels in full-term neonates managed for suspected early onset sepsis (EOS) due to probable maternal intrapartum sepsis.
Methods
Prospective longitudinal observational study at University Hospitals of Bristol NHS Foundation trust. Included were a total of 117 neonates managed for suspected EOS from June to October 2020. In addition to routine full-blood-counts and c-reactive protein (CRP) tests, serum PCT levels were also measured as part of the septic screen and follow-up blood tests. Placentas were sent for histopathology analysis.
Neonatal parameters were used to categorize cases into: “high-suspicion bacterial sepsis (BS),” “equivocal BS” and “low-suspicion BS.” Statistical test Kruskal-Wallis compared categories with biomarker values and placental histopathology scores.
Results
A higher percentage of PCT levels showed elevation in comparison to CRP levels in the initial testing (55.3% versus 5.9%) and follow-up testing (98.9% versus 35%). There was a significant difference between the “low-suspicion BS” and “high-suspicion BS” categories for both the initial and follow-up PCT results. 71.2% of placentas showed varying degrees of chorioamnionitis.
Conclusion
This study provides evidence to the physiological rise in PCT during the first few days of life. The significant difference in PCT levels according to clinical severity shows that PCT could be utilized in calculating odds for EOS, but as a standalone test will have limited use.
StollBJ, HansenNI, SanchezPJ, . Early onset neonatal sepsis: the burden of group B streptococcal and E. Coli disease continues. Pediatrics. 2011;127(5):817–826.
2.
WatsonG, CaldwellC and KenneaN. Neonatal early onset sepsis: a reflection on the NICE guidance. Infant. 2016;12(4):133–135.
3.
ChiesaC, PaneroA, StegagnoM., . Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin Infect Dis. 1998;26(3):664–672.
4.
SakhaK, HusseiniMB and SeyyedsadriN. The role of the procalcitonin in diagnosis of neonatal sepsis and correlation between procalcitonin and c-reactive protein in these patients. Pak J Biol Sci. 2008;11(14):1785–1790.
5.
GreerO, ShahNM, JohnsonMR. Maternal sepsis update: current management and controversies. Obstet Gynaecol. 2020;22(1):45–55.
6.
SnoekL, Van KasselMN, KrommenhoekJF, . Neonatal early-onset infections: comparing the severity of the neonatal early-onset sepsis calculator to the Dutch and the updated NICE guidelines in an observational cohort of culture-positive cases. E Clinical Medicine. 2022;44:101270.
CokerMO, HoenAG, DadeE, . Specific class of intrapartum antibiotics relates to maturation of the infant gut microbiota: a prospective cohort study. BJOG. 2020;127(2):217–227.
9.
TapiainenT, KoivusaariP, BrinkacL, . Impact of intrapartum and postnatal antibiotics on the gut microbiome and emergence of antimicrobial resistance in infants. Sci Rep. 2019;10635.
10.
WalkerS, HardingI, SoomreK, . An evaluation into the use of procalcitonin levels as a biomarker of bacterial sepsis to aid the management of intrapartum pyrexia and chorioamnionitis. AJOGGlob Rep. 2022; 2(3):100064.
11.
PontrelliG, De CrescenzoF, BuzzettiR, . Accuracy of serum procalcitonin for the diagnosis of sepsis in neonates and children with systemic inflammatory syndrome: a meta-analysis. BMC Infect Dis. 2017;17(1):302.
12.
WaldronCA, Thomas-JonesE, BernatonieneJ, . Biomarker-guided duration of Antibiotic Treatmnet in Children Hospitalised with confirmed or suspected bacterial infection (BATCH): protocol for a randomised controlled trial. BMJ Open. 2022;25(1):e047490.
13.
VijayanAL, Vanimaya, TavindranS, . Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy. J Intensive Care. 2017;5:51.
14.
TujulaB, KokkiH, RasanenJ, . Procalcitonin; a feasible biomarker for severe bacterial infections in obstetrics and gynecology?Acta Obstet Gynecol Scand. 2018;97(5):505–506.
15.
National institute for health and care excellence. Procalcitonin testing for diagnosing and monitoring sepsis (ADVIA Centaur BRAHMS PCT assay, BRAHMS PCT sensitive Kryptor assay, Elecsys BRAHMS PCT assay, LIASON BRAHMS PCT assay and VIDAS BRAHMS PCT assay). Diagnostic guidance 18. NICE; 2015. http://www.nice.org.uk/guidance/dg18.
16.
LeeJ, BangYH, LeeEH, . The influencing factors on procalcitonin values in newborns with noninfectious conditions during the first week of life. Korean J Pediatr. 2017;60(1):10–16.
17.
GkentziG and DimitriouG. Procalcitonin use for shorter courses of antibiotic therapy in suspected early-onset neonatal sepsis: are we getting there?J Thorac Dis. 2017;9(12):4899–4902.
18.
National Institute for Health and Care Excellence. Neonatal Infection: Antibiotics for Prevention and Treatment. NICE Guideline 195. 2021. https://www.nice.org.uk/guidance/ng195/chapter/Recommendations
19.
Elecsys BRAHMS Procalcitonin assay. Electrochemiluminescence immunoassay “ECLIA” for the in vitro quantitative determination of PCT (procalcitonin) in human serum and plasma. https://diagnostics.roche.com/global/en/products/params/elecsys-brahms-procalcitonin-pct.html. https://www.nortonsoundhealth.org/wp-content/uploads/Elecsys-BRAHMS-PCT.pdf
20.
SchuetzP, BeishuizenA, BroylesM, . Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use. Clin Chem Lab Med. 2019;57(9):1308–1318.
21.
RedlineRW, Faye-PetersenO, HellerD, QureshiF, . Amniotic infection syndrome: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol. 2003;6(5):435–448.
22.
KhongTY, MooneyEE, ArielI, . Sampling and definitions of placental lesions: Amsterdam Placental Workshop Group Consensus Statement. Arch Pathol Lab Med. 2016;140(7):698–713.
23.
KuzniewiczMW, WalshEM, SherianL, . Development and Implementation of an Early-onset sepsis calculator to guide antibiotic management in late preterm and term neonates. Jt Comm J Qual Patient Saf. 2016;42 (5):232–239.
24.
Kaiser Permanente Research. Neonatal Early-Onset Sepsis Calculator. https://neonatalsepsiscalculator.kaiserpermanente.org
25.
BossuytPM, ReitsmaJB, BrunsDE, . STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies. BMJ. 2015;28:(35):h5527.
26.
WatsonG, CaldwellC and KenneaN. Neonatal early onset sepsis: a reflection on the NICE guidance. Infant. 2016;12(4):133–135.
27.
BenitzWE, HanMY, MadanA, . Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Paediatrics. 1998;102(4):41.
28.
StockerM, Van HerkW, HelouSE, . Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial. Lancet. 2017;26(390):871–881.
29.
KoskenvuoMM, IrjalaK, KinnalaA, . Value of monitoring serum procalcitonin in neonates at risk of infection. Eur J Clin Microbiol Infect Dis. 2003;22(6):377–378.
30.
MonneretG, LabauneJM, IsaacC, . Procalcitonin and C-reactive protein levels in neonatal infections. Acta Paediatr. 1997;86(2):209–212.
31.
JessopF, SebireNJ. Histological chorioamnionitis: current concepts of diagnosis, classification and clinical significance. Fetal Matern Med Rev. 2011;22(1): 25–44.
GoldsteinJA, GallagherK, BeckC, . Maternal-fetal inflammation in the placenta and the developmental origins of health and disease. Front Immunol. 2020;13;11:531543.
TurnerD, HammermanC, RudenskyB, . Procalcitonin in preterm infants during the first few days of life: introducing an age related nomogram. Arch Dis Child Fetal Neonatal Ed. 2006;91(4):283–286.
